Lars Gredsted is a Senior Principal at Lundbeckfonden BioCapital, where they apply their extensive background in biomedical investment and development. Previously, Lars served as a Partner and Senior Business Analyst at the Wellcome Trust from 2012 to 2017, focusing on sourcing charitable investment opportunities. Lars holds a Ph.D. in Developmental Biology/Cancer Biology from Heidelberg University and an MPhil in Bioscience Enterprise from the University of Cambridge. Additionally, Lars has held various research and leadership positions across notable organizations such as AstraZeneca, MedImmune, and The Boston Consulting Group.
Location
Copenhagen, Denmark
This person is not in the org chart
This person is not in any teams
This person is not in any offices